OpenMedicare
Start Here
Explore
Fraud
Investigations
Data
Tools
About

Footer

OpenMedicare

Independent Medicare data journalism

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenSpending

Explore

  • Providers
  • Procedures
  • States
  • Specialties
  • Search

Fraud Analysis

  • Still Out There (AI)
  • Fraud Overview
  • Fraud Watchlist
  • Deep Dive Profiles
  • Impossible Numbers
  • Report Fraud

Investigations

  • The Algorithm Knows
  • How We Built the Model
  • Internal Medicine Crisis
  • Florida & California Fraud
  • Million Dollar Flagged
  • All Investigations

Tools

  • Provider Lookup
  • Compare
  • Cost Calculator
  • Your Medicare Dollar
  • Downloads

About

  • About OpenMedicare
  • Methodology
  • Glossary
  • Data Sources
  • API Docs
  • Updates
Data Sources: Centers for Medicare & Medicaid Services (CMS), Medicare Provider Utilization and Payment Data
Disclaimer: This site is an independent journalism project. Data analysis and editorial content are not affiliated with or endorsed by CMS or any government agency. All spending figures are based on publicly available Medicare payment records.
Sister Sites: OpenMedicaid ยท OpenFeds ยท OpenSpending

ยฉ 2026 OpenMedicare. Independent data journalism. Built by TheDataProject.ai

Methodologyโ€ขDownload Data
  1. Home
  2. Providers
  3. Theranostix Inc
๐Ÿ”ฌ
Organization

Theranostix Inc

NPI: 1992812473
Beltsville, MD
10 years of data
Clinical Laboratory
$61.4M
Total Payments
396
Beneficiaries
816.1K
Services
3.77x
Markup Ratio

Peer Comparison

98th
percentile in specialty
This provider$61.4M
Specialty median$1.9M
Rank #128 of 232 in specialty

๐Ÿ“‹ Key Findings

1Billed $61.4M over 10 years
23.77x markup ratio (above median)
398th percentile in Clinical Laboratory by payments
412 procedures with >3x markup
โœ“ No flags detected

๐Ÿ”Ž Data Analysis

This provider's $61.4M in total Medicare payments ranks in the 98th percentile of Clinical Laboratory providers nationally.

Medicare payments to this provider grew 115% from 2014 to 2023.

AI-generated analysis based on Medicare payment data.

Annual Medicare Payments

Annual Services Provided

Avg Payment per Service

Markup Ratio Over Time

Submitted Charges vs. Medicare Payments

Average per-service amounts submitted by the provider compared to what Medicare actually paid โ€” the gap represents the markup.

YearAvg SubmittedAvg PaidMarkup RatioGap per ServiceTotal PaymentsServicesBeneficiaries
2014$286.37$76.783.73x$209.59$2.4M30.9K10
2015$361.85$83.714.32x$278.14$3.2M37.8K14
2016$415.96$91.254.56x$324.71$4.5M49.2K20
2017$362.00$76.544.73x$285.46$5.3M68.6K29
2018$403.07$87.674.60x$315.40$6.8M77.6K34
2019$369.17$84.424.37x$284.75$6.9M82.2K29
2020$331.39$87.333.79x$244.06$9.4M107.2K42
2021$258.64$78.803.28x$179.84$9.0M114.4K54
2022$145.25$57.012.55x$88.24$8.9M156.7K70
2023$158.46$55.692.85x$102.77$5.1M91.7K94

Top Procedures (20)

88305Pathology examination of tissue using a microscope, intermediate complexityโš  4.3x markup
$9.5M
263.0K services$36.13/svc4.31x markup
88120Cell examination of urine, manualโš  4.0x markup
$7.7M
15.3K services$502.26/svc4.00x markup
88121Cell examination of urine, computer-assistedโš  4.3x markup
$6.8M
15.7K services$431.72/svc4.34x markup
88342Special stained specimen slides to examine tissue, initial procedureโš  4.3x markup
$5.1M
74.2K services$69.08/svc4.31x markup
88313Special stained specimen slides to examine tissue including interpretation and reportโš  4.0x markup
$4.9M
84.9K services$57.97/svc4.02x markup
U0003Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r
$4.0M
46.7K services$86.14/svc2.01x markup
G0416Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any methodโš  5.0x markup
$2.9M
10.7K services$268.12/svc4.99x markup
88312Special stained specimen slides to identify organisms including interpretation and reportโš  4.0x markup
$2.6M
33.7K services$77.71/svc3.97x markup
88112Cell examination of specimen, selective cellular enhancement techniqueโš  5.0x markup
$2.4M
55.5K services$42.63/svc4.95x markup
81266Comparative analysis using short tandem repeat (str) markers of patient and specimen, each additional specimen
$2.2M
7.2K services$301.61/svc2.84x markup
87798Detection test by nucleic acid for organism, amplified probe technique
$1.8M
51.7K services$34.44/svc1.17x markup
81265Comparative analysis using short tandem repeat (str) markers of patient and specimen
$1.7M
7.3K services$230.49/svc3.00x markup
88344Special stained specimen slides to examine tissue, each multiplex procedureโš  6.1x markup
$1.6M
14.0K services$117.40/svc6.07x markup
87507Detection test by nucleic acid for digestive tract pathogen, multiple types or subtypes, 12-25 targets
$1.3M
2.8K services$456.35/svc2.23x markup
88377Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedureโš  3.9x markup
$786.8K
2.5K services$319.82/svc3.90x markup
U0005Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within
$591.0K
23.8K services$24.86/svc2.01x markup
88341Special stained specimen slides to examine tissue, each additional procedureโš  4.6x markup
$572.3K
9.1K services$62.99/svc4.61x markup
87506Detection test by nucleic acid for digestive tract pathogen, multiple types or subtypes, 6-11 targetsโš  3.4x markup
$477.5K
1.8K services$260.07/svc3.37x markup
87481Detection test for candida species (yeast), amplified probe technique
$394.4K
11.5K services$34.43/svc1.16x markup
81162Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants
$328.8K
181 services$1.8K/svc1.25x markup
Show detailed table โ–พ
CodeDescriptionServicesPaymentsAvg/ServiceMarkup
88305Pathology examination of tissue using a microscope, intermediate complexity263.0K$9.5M$36.134.31x
88120Cell examination of urine, manual15.3K$7.7M$502.264.00x
88121Cell examination of urine, computer-assisted15.7K$6.8M$431.724.34x
88342Special stained specimen slides to examine tissue, initial procedure74.2K$5.1M$69.084.31x
88313Special stained specimen slides to examine tissue including interpretation and report84.9K$4.9M$57.974.02x
U0003Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r46.7K$4.0M$86.142.01x
G0416Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method10.7K$2.9M$268.124.99x
88312Special stained specimen slides to identify organisms including interpretation and report33.7K$2.6M$77.713.97x
88112Cell examination of specimen, selective cellular enhancement technique55.5K$2.4M$42.634.95x
81266Comparative analysis using short tandem repeat (str) markers of patient and specimen, each additional specimen7.2K$2.2M$301.612.84x
87798Detection test by nucleic acid for organism, amplified probe technique51.7K$1.8M$34.441.17x
81265Comparative analysis using short tandem repeat (str) markers of patient and specimen7.3K$1.7M$230.493.00x
88344Special stained specimen slides to examine tissue, each multiplex procedure14.0K$1.6M$117.406.07x
87507Detection test by nucleic acid for digestive tract pathogen, multiple types or subtypes, 12-25 targets2.8K$1.3M$456.352.23x
88377Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure2.5K$786.8K$319.823.90x
U0005Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within23.8K$591.0K$24.862.01x
88341Special stained specimen slides to examine tissue, each additional procedure9.1K$572.3K$62.994.61x
87506Detection test by nucleic acid for digestive tract pathogen, multiple types or subtypes, 6-11 targets1.8K$477.5K$260.073.37x
87481Detection test for candida species (yeast), amplified probe technique11.5K$394.4K$34.431.16x
81162Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants181$328.8K$1.8K1.25x

Markup Analysis

Charge-to-Payment Ratio

3.77x

This provider submits charges 3.77 times higher than what Medicare actually pays.

What This Means

A markup ratio of 3.77x means for every $100 Medicare pays, this provider initially charges $377. This is higher than the national average.

Location

Beltsville, MD

Provider Verification

Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.

Similar Providers

Other Clinical Laboratory providers in MD for peer comparison.

Theranostix Inc (you)
$61.4M
Quest Diagnostics Incorporated Mdโš ๏ธ
$318.4M
Genedx Llc
$67.3M
Realtox Labs, Llc
$53.6M
Cirrus Dx, Inc.
$37.3M
Meritus Medical Laboratory Llc
$35.9M
Show detailed table โ–พ
ProviderLocationTotal PaymentsStatus
Quest Diagnostics Incorporated MdBaltimore, MD$318.4Mโš ๏ธ Flagged
Genedx LlcGaithersburg, MD$67.3Mโœ“ Clear
Realtox Labs, LlcReisterstown, MD$53.6Mโœ“ Clear
Cirrus Dx, Inc.Rockville, MD$37.3Mโœ“ Clear
Meritus Medical Laboratory LlcHagerstown, MD$35.9Mโœ“ Clear

Related

Browse
โ† Back to Provider Directory
State
All providers in MD โ†’
Specialty
All Clinical Laboratory providers โ†’
Tool
Compare this provider โ†’
Analysis
Fraud Watchlist โ†’
Search
Search all providers โ†’

Share This Provider

Share this provider's Medicare payment information

Share:

Data Sources

  • โ€ข Centers for Medicare & Medicaid Services (CMS)
  • โ€ข Medicare Provider Utilization and Payment Data (2014-2023)
  • โ€ข National Plan and Provider Enumeration System (NPPES)

Last Updated: February 2026 (data through 2023, the latest CMS release)

Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.

Believe this data is inaccurate? Dispute this data